Search Results

PF-543 2 mg  | Purity Not Available

TargetMol

PF-543 (Sphingosine Kinase 1 Inhibitor II), a novel sphingosine-competitive inhibitor of SphK1, inhibits SphK1 with IC50 and Ki of 2.0 nM and 3.6 nM.

More Information Supplier Page

GSK343 100 mg  | 99.90%

TargetMol

GSK343, a specific and effective EZH2 inhibitor (IC50=4 nM), exhibits 60 fold specificity activity against EZH1, and >1000 fold specificity activity against other histone methyltransferases.

More Information Supplier Page

GSK343 25 mg  | 99.90%

TargetMol

GSK343, a specific and effective EZH2 inhibitor (IC50=4 nM), exhibits 60 fold specificity activity against EZH1, and >1000 fold specificity activity against other histone methyltransferases.

More Information Supplier Page

URMC-099 100 mg  | Purity Not Available

TargetMol

URMC-099 is an orally bioavailable, brain penetrant MLK inhibitor (IC50: 19/42/14/150 nM, for MLK1/MLK2/MLK3/DLK), and also inhibits LRRK2 activity (IC50: 11 nM).

More Information Supplier Page

OSS_128167 10 mg  | Purity Not Available

TargetMol

OSS_128167 is a specific SIRT6 inhibitor, and for SIRT6(IC50=89 μM), SIRT1(IC50=1578 μM) and SIRT2(IC50=751 μM).

More Information Supplier Page

OSS_128167 5 mg  | Purity Not Available

TargetMol

OSS_128167 is a specific SIRT6 inhibitor, and for SIRT6(IC50=89 μM), SIRT1(IC50=1578 μM) and SIRT2(IC50=751 μM).

More Information Supplier Page

OSS_128167 2 mg  | Purity Not Available

TargetMol

OSS_128167 is a specific SIRT6 inhibitor, and for SIRT6(IC50=89 μM), SIRT1(IC50=1578 μM) and SIRT2(IC50=751 μM).

More Information Supplier Page